FrameworkClosed
Supply of New Sterile Connection Devices
NHS Blood and Transplant · £1,000,000 · closes 11 Jan 2024
£1,000,000
Estimated value
Closed
Deadline
4 Dec 2023
Published
This tender has closed.
See what's open in medical equipment and pharmaceuticals, or get contracts like this in your inbox each morning — free.
About this contract
Supply of Sterile Connection Devices, Consumables, Repair and Maintenance
Key dates
Published4 Dec 2023
Submission deadline11 Jan 2024 Add to calendar ↓
Source
Source notice on Find a TenderView ↗
Lot — bid on it if it fits
This contract has one lot. Bid if it suits your firm.
NHS Blood and Transplant (NHSBT) is a special health authority providing a blood and transplantation service to the NHS, looking after blood donation services in England and transplant services across the UK. This includes managing the donation, storage and transplantation of blood and blood components, organs, tissues, bone marrow and stem cells, and researching new treatments and processes.<br/><br/>As an essential part of the NHS we take pride in playing our part to make the most of absolutely every donation – from blood and organs to tissues and stem cells. With the support of our amazing donors, we give a lifeline to thousands of people every year. But there is always more to do, which is why we continually strive to improve the safety, availability, quality and efficiency of our services.<br/><br/>SCDs are essential for NHSBT to produce a wide range of blood components. They are used to connect ancillary packs to primary components to allow the manufacture of secondary components (washed red cells or platelets), in the production of pooled components (platelets, granulocytes and cryoprecipitate) and to manufacture neonatal split components (red cells, plasma and platelets). SCD’s are also used during bacterial screening and in areas outside of blood supply such as Tissue Services, Cellular and Molecular Therapy (CMT). <br/><br/>SCDs are essential for NHSBT to produce a wide range of blood components. They are used to connect ancillary packs to primary components to allow the manufacture of secondary components (washed red cells or platelets), in the production of pooled components (platelets, granulocytes and cryoprecipitate) and to manufacture neonatal split components (red cells, plasma and platelets). SCD’s are also used during bacterial screening and in areas outside of blood supply such as Tissue Services, Cellular and Molecular Therapy (CMT). <br/><br/>This framework is being conducted via our Atamis portal: https://health-family.force.com/s/Welcome£1,000,000
Who to contact
Similar open tenders
closes 2 Jan 2031
Contains public sector information licensed under OGL v3.0